Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Pharmaceuticals & Biotech
Create a narrative
SCHOTT Pharma KGaA Community
XTRA:1SXP Community
3
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Community Investing Ideas
SCHOTT Pharma KGaA
Popular
Undervalued
Overvalued
SCHOTT Pharma KGaA
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Aging Demographics And Biologics Will Expand Pharmaceutical Packaging Demand
Key Takeaways Surging demand for advanced injectable packaging and strong operational execution are delivering accelerated margin gains and positioning for long-term earnings growth. Innovation leadership, premium pricing power, and resilience to industry pressures ensure outsized growth prospects as healthcare trends drive persistent, global demand.
View narrative
€36.00
FV
35.8% undervalued
intrinsic discount
12.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
SCHOTT Pharma KGaA
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Increasing Environmental Regulations And Supply Chain Risks Will Erode Profitability
Key Takeaways Regulatory shifts towards sustainability and stricter packaging rules threaten increased costs, margin pressure, and reduced profitability for SCHOTT Pharma. Rising competition, shifting buyer power, and evolving drug delivery technologies risk eroding pricing, revenue growth, and long-term market share.
View narrative
€23.00
FV
0.4% overvalued
intrinsic discount
10.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
30 days ago
author updated this narrative
SCHOTT Pharma KGaA
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Advanced Drug Delivery And Capacity Investments Will Shape Future Success
Key Takeaways Expanding high-value solutions and strategic partnerships fuel revenue growth, improved margins, and long-term financial stability in advanced drug delivery packaging markets. Sustainability initiatives and operational efficiency measures enhance profitability, competitive positioning, and support ongoing margin and earnings expansion.
View narrative
€29.34
FV
21.3% undervalued
intrinsic discount
9.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
1SXP
1SXP
SCHOTT Pharma KGaA
Your Fair Value
€
Current Price
€23.10
8.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
2b
2015
2018
2021
2024
2025
2027
2030
Revenue €1.5b
Earnings €226.3m
Advanced
Set Fair Value